PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL ...Middle East

PR Newswire - News
PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL
F-18 Pivalate PET shows high uptake regardless of origin of primary tumour F-18 Pivalate can be used to monitor cerebral metastases Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake MELBOURNE,...

Hence then, the article about pivalate achieves positive phase 2 data in brain mets trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News